Moderna says that it COVID-19 vaccine continues to show 'strong efficacy'
Moderna Inc. said late Tuesday that its COVID-19 vaccine continued to show "strong efficacy," including greater than 90% efficacy against cases of COVID-19 and greater than 95% against severe cases of COVID-19 in a median six-month follow-up. New preclinical data also showed variant-specific booster vaccine candidates working, the company said. "We are looking forward to having the clinical data from our variant-specific booster candidates" as well as clinical data from a study of the vaccine in teens... Читать дальше...